Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This week, the top managed care stories included a huge ruling against one opioid maker and a settlement offer from another; an expert panel calling for broader screening for hepatitis C; a review showing there are more fatal events linked to a multiple sclerosis drug than previously known.
Listen above or through one of these podcast services:
What We're Reading: Purdue Pharma Settlement; HCV Screening; Medicare for All Support
Fatal AEs Associated With Alemtuzumab for MS May Occur More Frequently Than Previously Thought
FDA Grants Fast Track Designation for Dapagliflozin to Prevent Kidney Failure
5 Things to Look for at the European Society of Cardiology 2019 Congress
Keeping Glucose in Range, With the Right Tools and Treatment for Management
IVBM: Advancing Oncology Quality Through Value-Based Care
Read more about the stories in this podcast:
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Serum Neurofilament Light Changes Not Always Apparent in Active RRMS, Study Finds
May 8th 2024A prospective study found evidence of serum neurofilament light (sNfL) level increases in patients affected by active forms of relapsing-remitting multiple sclerosis (RRMS); however, these findings were not significant enough to suggest sNfL measurements replace clinical or MRI monitoring of disease activity.
Read More